US Aerospace And Defense Expansion Will Harness Industry 40 Trends

Key Takeaways

• Capacity expansions, specialized investments, and focus on high-growth markets position Bodycote for accelerated revenue growth, market share gains, and a stronger business mix.
  
• Continued innovation, optimization, and sustainability initiatives enhance pricing power, expand margins, and support long-term competitiveness in advanced material processing sectors.
  
• Shrinking core markets, sector volatility, margin pressures, rising costs, and technological shifts threaten Bodycote's revenue stability and demand urgent adaptation to sustain growth.

Catalysts

Provides heat treatment and thermal processing services worldwide.

• Major capacity expansions and upgrades in U.S. aerospace and defense sites are positioning Bodycote to capture higher demand as supply chain constraints ease and OEM order books grow, supporting future revenue acceleration and market share gains in these high-growth, high-margin sectors.
  
• The company's targeted organic investments, focused M&A pipeline, and increased sales capability in specialized markets such as aerospace, defense, and medical devices diversify revenue sources and are expected to drive above-market growth while improving business mix, ultimately benefiting top-line growth and margin profile.
  
• Momentum in Industry 4.0-related Specialist Technologies, such as HIP (Hot Isostatic Pressing) and vacuum treatments, combined with contract wins in defense and energy, position Bodycote at the forefront of increasing customer requirements for advanced material processing, translating to enhanced pricing power and improved net margins.
  
• The expanded Optimise program, including site consolidations and divestitures of low-margin and structurally lower-growth assets, is set to deliver at least £15 million in recurring annual cost benefits by mid-2027, materially boosting EBIT margins and cash flow.
  
• Bodycote's rollout of its Carbon Smart program-offering customers reduced carbon footprint heat treatment solutions-aligns with growing sustainability and electrification trends across automotive and industrial sectors, enabling the company to maintain pricing power, win new business, and protect or expand margins as decarbonization pressures mount.

Bodycote Future Earnings and Revenue Growth

Assumptions

• Analysts are assuming Bodycote's revenue will decrease by 0.1% annually over the next 3 years.
• Analysts assume that profit margins will increase from 3.9% today to 15.7% in 3 years time.
• Analysts expect earnings to reach £114.7 million (and earnings per share of £0.51) by about September 2028, up from £28.4 million today.
• In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 13.9x on those 2028 earnings, down from 39.0x today. This future PE is lower than the current PE for the GB Machinery industry at 22.9x.
• Analysts expect the number of shares outstanding to decline by 1.59% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 8.55%, as per the Simply Wall St company report.

Bodycote Future Earnings Per Share Growth

Risks

• Bodycote's ongoing exposure to structurally weak and declining end markets, especially in Western Europe automotive and industrial segments, is leading to the closure or divestiture of up to 20% of its site portfolio and losing approximately £60 million in annual revenues; continued weakness in these sectors presents a risk of prolonged revenue stagnation or further contraction.
  
• Over-reliance on cyclical sectors like aerospace and defense could result in earnings volatility; while these segments presently offer growth, any downturns or supply chain disruptions in these industries could quickly translate into significant drops in revenue and profitability.
  
• Persistent pricing pressures and weak demand in several end markets, combined with the need to pass on surcharges or negotiate with large OEMs, could limit Bodycote's ability to maintain or expand margins over time, especially as peers in the space experience similar stresses.
  
• Rising compliance, restructuring, and capital costs-including a 10% year-over-year increase in capex and substantial restructuring spend tied to site closures-may erode cash flow and net margins, particularly if the anticipated efficiency gains and cost savings from the Optimise program fail to fully materialize.
  
• Increasing adoption of new technologies such as additive manufacturing, as well as heightened ESG and decarbonization requirements, could threaten demand for traditional heat treatment processes, forcing Bodycote to accelerate investment in next-generation solutions or risk long-term revenue decline and market share erosion.

Valuation

• The analysts have a consensus price target of £7.438 for Bodycote based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of £8.45, and the most bearish reporting a price target of just £6.1.
• In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be £730.0 million, earnings will come to £114.7 million, and it would be trading on a PE ratio of 13.9x, assuming you use a discount rate of 8.6%.
• Given the current share price of £6.28, the analyst price target of £7.44 is 15.5% higher.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.